Page 36 - Summer2014
P. 36

High     plaque present and its density are directly influ-  of time, and the functional “hyperglycemia”

             cholesterol      enced by ApoE genotype, with E4 homozygotes  in the brain will provide an elevated level of
                              having the densest and most extensive plaques.  glucose—the perfect storm for glycation of Aβ
           levels later in    Sections from the brains of homozygous ApoE4  and its aggregation into insoluble plaques. As
                   life are   AD patients are so riddled with Aβ plaques that  if that were not challenge enough for a brain
              associated      they can often be distinguished from those of E3  that is already struggling to metabolize fuel ef-
                                                                         ficiently, AGEs themselves have been shown to
                              carriers without a microscope.
                                                        32
          with reduced            ApoE particles themselves have been  be neurotoxic, likely by inducing apoptosis (cell
                    risk of   identified in amyloid plaques. However, strong  death) and lipid peroxidation—a process that is
              dementia.       evidence that they bind directly to the plaques  especially damaging to cells whose membranes
                              is lacking. What has been established is the fact  are particularly rich in PUFAs.
                                                                                                   10,33
                              that ApoE particles bind to advanced glycation     Similar to the reduction in the CMRglu,
                              end products (AGEs), and yet another factor  AGE accumulation is a normal product of aging,
                              contributing to the insolubility of the plaques is  but AGE formation occurs more quickly and to a
                              their degree of glycation. The plaques become  greater degree in AD patients. AD brains show
                              glycated (bonded to sugar) and form cross-link-  more AGEs than those of healthy, age-matched
                              ages with each other, resulting in toxic AGEs. It  controls.  ApoE4 particles have been shown
                                                                                34
                              is the glycated plaques and AGEs that the ApoE  to have three times greater AGE-binding af-
                              particles actually bind to. Glycation is a factor  finity than ApoE3, and apolipoprotein particles
                              of glucose concentration exposure and time,  themselves are subject to glycation. Increased
                              with more AGEs forming upon longer exposure  glycated ApoE particles have been detected in
                              to higher concentrations of glucose.  It follows  the cerebrospinal fluid (CSF) of AD patients. 34,35
                                                            33
                              that in a body that is hyperinsulinemic, and a  The physiological insult of glycated ApoE is that
                              brain that is insulin-resistant, the peripheral  ApoE helps transport LDL particles (and their
                              hyperinsulinism will inhibit the clearance of  critical cholesterol and fatty acid passengers)
                              soluble Aβ by IDE, thereby causing it to remain  across the blood brain barrier. LDL containing
                              in the extracellular space for an extended amount  normal ApoE will be recognized by its receptor


                                  WHAT TO AVOID TO HELP PREVENT ALZHEIMER'S DISEASE

           •   STATIN DRUGS: Cholesterol is a vital part of the myelin sheath insulating neurons and assisting in propagation of
              nerve impulses; metabolites in the cholesterol biosynthesis pathway inhibited by statins are required to produce CoQ 10
              as well as functional GLUT4s. Cholesterol is also an integral part of plasma membranes, lending structural stability.
              Any pharmaceutically-induced disruption in endogenous synthesis of cholesterol—especially when combined with
              long-standing, population-wide recommendations to limit dietary intake—would starve the struggling brain of this
              absolutely critical nutrient. In fact, high cholesterol levels later in life are associated with reduced risk of dementia,
              and the CSF of AD patients has been shown to be lower in cholesterol than that of healthy controls. 62,63  HMG CoA
              reductase—the target of statin therapy—is abundant in brain cells. They require a constant supply of cholesterol, and
              when its production is inhibited, the result is a loss of myelin as well as malformation of membranes—including those
              of the mitochondria.  Compromised mitochondrial function deprives the brain of ATP. It is no surprise that decades
                               8
              of recommendations to reduce consumption of cholesterol and perhaps overzealous prescription of statin drugs have
              paralleled the rise in AD incidence.
                                            6
           •   PROCESSED FOODS: These present a quadruple nutritional assault upon a brain suffering the ravages of the modern
              diet: they are usually high in refined carbohydrate; high in rancid, easily oxidized vegetable oils; low in antioxidants;
              and low in vitamins and minerals.

           •   EXOGENOUS INSULIN: Although insulin has been shown to improve memory and cognition acutely, chronically
              high insulin levels are known to impair brain function. 42,64  Exogenous insulin would serve to inhibit IDE more strongly,
              thereby preventing the clearance of Aβ, causing it to linger in the brain interstitial fluid even longer, where it is sub-
              ject to glycation and oxidation. As noted, the greatest risk for AD is reserved for ApoE4 carriers who are treated with
              exogenous insulin.
         36                                         Wise Traditions                               SUMMER 2014                                                                 Wise Traditions





   137720_text.indd   36                                                                                       7/1/14   11:40 AM
   31   32   33   34   35   36   37   38   39   40   41